Zinc Lozenge Dosing in Reference #2
Reference #2 (the 2020 European Position Paper on Rhinosinusitis and Nasal Polyps) recommends zinc acetate or zinc gluconate lozenges at a dose of ≥75 mg/day, taken within 24 hours of symptom onset and continued throughout the duration of the common cold. 1
Dosing Details from the Guideline
The specific regimen outlined includes:
- Total daily dose: ≥75 mg elemental zinc per day
- Formulation: Either zinc acetate or zinc gluconate lozenges
- Timing of initiation: Within 24 hours of symptom onset
- Duration: Throughout the cold (continued until symptoms resolve)
- Frequency: The guideline references dosing every 2-3 hours while awake based on the underlying evidence 1
Supporting Evidence and Context
This recommendation is reinforced by the same guideline's summary table, which states that zinc "significantly reduces the duration of common cold" when administered at this dose 1. The guideline explicitly notes that the likely benefit must be balanced against side effects, notably bad taste and nausea 1.
Important Caveats
The ≥75 mg/day threshold is critical: Lower doses have not shown consistent efficacy. Studies using doses below this threshold (such as 4.5 mg every 1.5 hours or 10 mg every 2-3 hours) failed to demonstrate benefit 2
Formulation matters: The guideline specifically mentions zinc acetate or zinc gluconate because these forms release adequate ionic zinc at physiological pH, which is believed to be the active component 1
Early initiation is essential: The 24-hour window from symptom onset is emphasized as crucial for efficacy 1